Niemann-Pick Type A PerlQuest

Wylder Nation Logo

“Perlara’s unique drug discovery platform and business model is a perfect fit for advancing our efforts in discovering existing compounds that can be repurposed, and new novel compounds that can be optimized for treating Niemann-Pick Type A,”

— Steven Laffoon, Co-Founder and President of Wylder Nation Foundation

Our Progress

We got off to a running start in January, and we’re looking forward to seeing initial data in the second quarter. We’ll keep you posted about progress as we move along.

Launch your own PerlQuest

Still have questions about PerlQuests?

Follow other PerlQuests

NGLY1 PerlQuest icon 440x260px
PMM2-CDG PerlQuest icon 440x260px

PerlQuest updates from our Blog

Hit to lead, lead to partnership

This is the fourth post in an open science blog series about PERL101 (P101), a small molecule with big hopes. Demystifying drug discovery The default setting of biotech startups and pharma giants alike is stealth mode. At Perlara the default is set to open. As the...

read more

Perlara logo 300x108px

Join our mailing list

Translate »